Boston Scientific (NYSE:BSX) will have a transition at the top of its Cardiac Rhythm Management & Diagnostics (CRMDx) ...

Biomedical engineers set the foundation for a ground-breaking treatment regimen for treating ventricular arrhythmia. The study demonstrates the design and feasibility of a new hydrogel-based pacing ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

An update from MicroPort CardioFlow Medtech Corp. ( ($HK:2160) ) is now available. MicroPort CardioFlow Medtech Corporation has completed the ...

Experts note that implantable loop recorders are valuable for detecting infrequent arrhythmias and guiding anticoagulation decisions post-cryptogenic stroke or atrial fibrillation ablation, but due to ...

Experts discuss how arrhythmia evaluation is tailored based on symptom frequency, severity, and patient risk, using a stepwise approach from short-term to extended monitoring to guide timely and ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

It’s time for spring cleaning, and first on Medtronic’s to-do list is the reorganization of several of its field-specific medical device segments. In addition to splitting up its cardiovascular and ...

On November 17, HSHS St. Elizabeth’s Hospital performed our first laser lead extraction. This innovative, specialized ...

New ACC/AHA guidelines provide updated management strategies for the growing population of adults living with congenital heart disease.

MAURIZIO SARRI has had heart surgery after being diagnosed with a rhythm disorder. The former Chelsea boss, 66, now in charge ...